Pharmaron Raises $589 Million in Hong Kong Listing

(Bloomberg) -- Chinese contract drugmaker Pharmaron Beijing Co. raised HK$4.6 billion ($589 million) after pricing its Hong Kong listing at the top end of a marketed range, people familiar with the...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.